Management of COPD Exacerbations

Systemic Corticosteroids

The American Academy of Family Physicians recommends systemic corticosteroids as the primary treatment for acute COPD exacerbations, with a dosing regimen of prednisone 30-40 mg orally once daily for 5 days 1, 2
Oral administration of corticosteroids is preferred over intravenous, as it is associated with fewer adverse effects, shorter hospital stays, and lower costs without compromising efficacy 2
Five days of corticosteroid treatment is as effective as 14 days, with significantly fewer adverse effects, including reduced rates of pneumonia-associated hospitalization and mortality 1, 3, 2
Systemic corticosteroids reduce clinical failure rates, shorten recovery time, improve lung function and oxygenation, and reduce the risk of relapse within the first 30 days 1, 2

The American Thoracic Society recommends adding antibiotics if the patient has at least two of the following criteria: increased breathlessness, increased sputum volume, or purulent sputum 4
The choice of antibiotic should be guided by local resistance patterns 3

The American Academy of Family Physicians recommends intensifying short-acting bronchodilators during exacerbations, including increasing the frequency of albuterol and considering the addition of ipratropium bromide 5, 1, 3
Ensuring proper inhaler technique and considering nebulizer delivery if the patient cannot use the inhaler effectively during acute dyspnea is crucial 4

The American College of Chest Physicians recommends considering roflumilast (PDE-4 inhibitor) for moderate to severe COPD with chronic bronchitis and a history of at least one exacerbation in the previous year, at a dose of 500 mcg once daily 6, 7
N-Acetylcysteine (mucolytic) may reduce exacerbation frequency with low risk of adverse effects in moderate to severe COPD with a history of two or more exacerbations in the previous 2 years 6, 7
Theophylline may be considered for stable COPD patients continuing to have periodic exacerbations despite maintenance therapy, with a dosing regimen of oral slow-release formulation twice daily 6, 7

The American College of Chest Physicians recommends never using systemic corticosteroids beyond 30 days for preventing subsequent exacerbations, as no evidence supports long-term use and risks outweigh benefits 6, 7, 2
The American Academy of Family Physicians recommends avoiding high-flow oxygen if supplemental oxygen is needed, and instead using titrated oxygen to maintain appropriate saturation levels, as high-flow oxygen is associated with increased mortality 1, 3